Dr. Awal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2300 M St NW
Washington, DC 20037Phone+1 202-741-2389
Education & Training
St. George's University School of MedicineClass of 2016
Clinical Trials
- Impact of Semaglutide on CD34+ EPC and Fat Derived MSC Start of enrollment: 2019 Aug 01
Roles: Contact
Publications & Presentations
PubMed
- 3 citationsCardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells.Adrian Farid Elzarki, Seshagiri Rao Nandula, Hassan Awal, Gary L Simon, Sabyasachi Sen
Stem Cell Research & Therapy. 2022-03-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
